EID Parry (India) Ltd

NSE: EIDPARRY BSE: 500125

EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]

₹772

52W: ₹751 — ₹1247

PE 391 · Book ₹127 · +508% vs book

Market Cap₹13,726 Cr

Stock P/E391Price to Earnings

ROCE1.66%Return on Capital

ROE0.79%Return on Equity

Div. Yield0%Face Value ₹1

Strengths

+Company's working capital requirements have reduced from 58.0 days to 40.2 days

Weaknesses

−Stock is trading at 5.99 times its book value
−The company has delivered a poor sales growth of 11.1% over past five years.
−Company has a low return on equity of 4.09% over last 3 years.
−Promoter holding has decreased over last 3 years: -3.10%

Shareholding Pattern

Promoters41.45%

FIIs12.2%

DIIs16.75%

Public29.59%

Category	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	42.24%	42.23%▼0.0	41.7%▼0.5	41.62%▼0.1	41.55%▼0.1	41.49%▼0.1	41.45%▼0.0	41.45%
FIIs	10.22%	10.66%▲0.4	12.64%▲2.0	12.17%▼0.5	12.66%▲0.5	12.77%▲0.1	12.61%▼0.2	12.2%▼0.4
DIIs	12.45%	13.29%▲0.8	13.29%	13.83%▲0.5	14.46%▲0.6	15.57%▲1.1	16.28%▲0.7	16.75%▲0.5
Public	35.09%	33.83%▼1.3	32.38%▼1.4	32.38%	31.32%▼1.1	30.17%▼1.1	29.66%▼0.5	29.59%▼0.1

Financial Statements

Metric	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	726	668	717	751	755	848	814	760	754	773
Expenses	726	659	570	801	796	882	725	791	803	814
Operating Profit	-1	9	147	-50	-41	-34	88	-31	-50	-41
OPM %	0%	1%	20%	-7%	-5%	-4%	11%	-4%	-7%	-5%
Net Profit	86	-14	80	-79	28	-146	-232	-28	-286	-54
EPS ₹	4.85	-0.77	4.52	-4.43	1.59	-8.24	-13.03	-1.57	-16.06	-3.06

AI Insights

Revenue Trend

TTM revenue at ₹3,100Cr, down 2.1% YoY. OPM at -1%.

Debt Position

Borrowings at ₹964Cr. Debt-to-equity ratio: 0.43x. Healthy balance sheet.

Capex Cycle

CWIP at ₹28Cr (2% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 16.75% (+11.99pp change). FIIs: 12.2% (+1.80pp change). Promoters hold 41.45%.

Margin & Efficiency

ROCE declining from 4% (Mar 2014) to 2% (Mar 2025). Working capital days: 40.

Valuation

PE 391x with 1.66% ROCE. Price is 508% above book value of ₹127. Dividend yield: 0%.